Sébastien Rinaldetti
- Co-authors
- Thomas Stefan WorstArndt HartmannPhilipp ErbenQiong ZhouDaniel V. LaBarberaRalph M. WirtzMarkus EcksteinJohannes Breyer
- Topics
- Bladder and Urothelial Cancer Treatments (8 papers)Urinary and Genital Oncology Studies (4 papers)Ferroptosis and cancer prognosis (4 papers)
- Cited by
- Cancer ResearchOncologyHematology
- Partner nations
- GermanyUnited StatesLuxembourg
In The Last Decade
Sébastien Rinaldetti
16 papers receiving 203 citations
Peers
Comparison fields: 5 of 37
- Molecular Biology 112
- Surgery 74
- Oncology 55
- Cancer Research 44
- Pulmonary and Respiratory Medicine 42
Countries citing papers authored by Sébastien Rinaldetti
This map shows the geographic impact of Sébastien Rinaldetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sébastien Rinaldetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sébastien Rinaldetti more than expected).
Fields of papers citing papers by Sébastien Rinaldetti
This network shows the impact of papers produced by Sébastien Rinaldetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sébastien Rinaldetti. The network helps show where Sébastien Rinaldetti may publish in the future.
Co-authorship network of co-authors of Sébastien Rinaldetti
This figure shows the co-authorship network connecting the top 25 collaborators of Sébastien Rinaldetti. A scholar is included among the top collaborators of Sébastien Rinaldetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sébastien Rinaldetti. Sébastien Rinaldetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 18 | |
| 5 | 42 | |
| 6 | 23 | |
| 7 | 2 | |
| 8 | 9 | |
| 9 | 16 | |
| 10 | 12 | |
| 11 | 17 | |
| 12 | 4 | |
| 13 | 21 | |
| 14 | 19 | |
| 15 | 15 | |
| 16 | 2 | |
| 17 | Major route additional chromosomal aberrations (ACA) precede increase of blasts in chronic myeloid leukemia (CML) independent of therapy. An analysis of CML studies III, IIIA and IV | 1 |
About Sébastien Rinaldetti
Sébastien Rinaldetti is a scholar working on Hematology, Biotechnology and Oncology, having authored 17 papers that have together received 204 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (8 papers), Urinary and Genital Oncology Studies (4 papers) and Ferroptosis and cancer prognosis (4 papers). The work is most often cited by research in Cancer Research (44 citations), Oncology (55 citations) and Hematology (21 citations). Sébastien Rinaldetti has collaborated with scholars based in Germany, United States and Luxembourg. Frequent co-authors include Thomas Stefan Worst, Arndt Hartmann, Philipp Erben, Qiong Zhou, Daniel V. LaBarbera, Ralph M. Wirtz, Markus Eckstein, Johannes Breyer, Christian Bolenz and Robert T. Jones. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.